科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/03/22 | 4,585 | 4,630 | 4,575 | 4,615 | +30 | +0.7% | 167,600 |
| 2021/03/19 | 4,555 | 4,610 | 4,540 | 4,585 | ±0 | ±0% | 230,000 |
| 2021/03/18 | 4,590 | 4,625 | 4,560 | 4,585 | +30 | +0.7% | 192,800 |
| 2021/03/17 | 4,475 | 4,555 | 4,450 | 4,555 | +120 | +2.7% | 143,900 |
| 2021/03/16 | 4,480 | 4,480 | 4,410 | 4,435 | -5 | -0.1% | 141,300 |
| 2021/03/15 | 4,305 | 4,440 | 4,305 | 4,440 | +145 | +3.4% | 213,600 |
| 2021/03/12 | 4,375 | 4,375 | 4,285 | 4,295 | -100 | -2.3% | 257,300 |
| 2021/03/11 | 4,470 | 4,485 | 4,375 | 4,395 | -60 | -1.3% | 186,700 |
| 2021/03/10 | 4,520 | 4,575 | 4,425 | 4,455 | +40 | +0.9% | 299,100 |
| 2021/03/09 | 4,300 | 4,420 | 4,290 | 4,415 | +160 | +3.8% | 224,000 |
| 2021/03/08 | 4,255 | 4,290 | 4,240 | 4,255 | +10 | +0.2% | 136,200 |
| 2021/03/05 | 4,250 | 4,275 | 4,220 | 4,245 | -10 | -0.2% | 250,300 |
| 2021/03/04 | 4,290 | 4,290 | 4,220 | 4,255 | -15 | -0.4% | 152,000 |
| 2021/03/03 | 4,285 | 4,295 | 4,235 | 4,270 | +20 | +0.5% | 139,300 |
| 2021/03/02 | 4,265 | 4,280 | 4,230 | 4,250 | ±0 | ±0% | 188,100 |
| 2021/03/01 | 4,260 | 4,265 | 4,205 | 4,250 | +15 | +0.4% | 240,400 |
| 2021/02/26 | 4,300 | 4,300 | 4,220 | 4,235 | +25 | +0.6% | 268,300 |
| 2021/02/25 | 4,240 | 4,245 | 4,170 | 4,210 | +20 | +0.5% | 138,500 |
| 2021/02/24 | 4,205 | 4,265 | 4,170 | 4,190 | +35 | +0.8% | 177,400 |
| 2021/02/22 | 4,150 | 4,200 | 4,135 | 4,155 | +10 | +0.2% | 153,600 |
| 2021/02/19 | 4,190 | 4,205 | 4,130 | 4,145 | -75 | -1.8% | 174,700 |
| 2021/02/18 | 4,225 | 4,235 | 4,190 | 4,220 | ±0 | ±0% | 146,600 |
| 2021/02/17 | 4,175 | 4,280 | 4,160 | 4,220 | +60 | +1.4% | 291,100 |
| 2021/02/16 | 4,115 | 4,170 | 4,115 | 4,160 | +50 | +1.2% | 175,700 |
| 2021/02/15 | 4,100 | 4,130 | 4,085 | 4,110 | +15 | +0.4% | 116,000 |
| 2021/02/12 | 4,060 | 4,095 | 4,040 | 4,095 | +75 | +1.9% | 199,100 |
| 2021/02/10 | 4,080 | 4,090 | 4,020 | 4,020 | -85 | -2.1% | 253,500 |
| 2021/02/09 | 4,105 | 4,135 | 4,075 | 4,105 | -25 | -0.6% | 201,200 |
| 2021/02/08 | 4,125 | 4,145 | 4,090 | 4,130 | -15 | -0.4% | 142,000 |
| 2021/02/05 | 4,125 | 4,150 | 4,110 | 4,145 | +20 | +0.5% | 108,900 |
| 2021/02/04 | 4,120 | 4,165 | 4,105 | 4,125 | +10 | +0.2% | 164,100 |
| 2021/02/03 | 4,050 | 4,135 | 4,045 | 4,115 | +40 | +1% | 147,200 |
| 2021/02/02 | 4,090 | 4,125 | 4,055 | 4,075 | -25 | -0.6% | 131,400 |
| 2021/02/01 | 4,120 | 4,140 | 4,085 | 4,100 | ±0 | ±0% | 138,000 |
| 2021/01/29 | 4,105 | 4,160 | 4,085 | 4,100 | -30 | -0.7% | 201,000 |
| 2021/01/28 | 4,050 | 4,140 | 4,050 | 4,130 | +15 | +0.4% | 168,700 |
| 2021/01/27 | 4,095 | 4,135 | 4,090 | 4,115 | +15 | +0.4% | 193,900 |
| 2021/01/26 | 4,080 | 4,115 | 4,075 | 4,100 | ±0 | ±0% | 111,500 |
| 2021/01/25 | 4,100 | 4,125 | 4,075 | 4,100 | +35 | +0.9% | 93,500 |
| 2021/01/22 | 4,040 | 4,085 | 4,035 | 4,065 | -25 | -0.6% | 123,300 |
| 2021/01/21 | 4,030 | 4,110 | 4,025 | 4,090 | +70 | +1.7% | 179,700 |
| 2021/01/20 | 4,030 | 4,040 | 3,990 | 4,020 | +5 | +0.1% | 262,600 |
| 2021/01/19 | 4,065 | 4,070 | 4,000 | 4,015 | -70 | -1.7% | 182,800 |
| 2021/01/18 | 4,110 | 4,115 | 4,055 | 4,085 | -35 | -0.8% | 157,200 |
| 2021/01/15 | 4,130 | 4,140 | 4,105 | 4,120 | -25 | -0.6% | 144,100 |
| 2021/01/14 | 4,090 | 4,145 | 4,045 | 4,145 | +40 | +1% | 234,200 |
| 2021/01/13 | 4,145 | 4,150 | 4,100 | 4,105 | -30 | -0.7% | 162,500 |
| 2021/01/12 | 4,110 | 4,170 | 4,105 | 4,135 | +40 | +1% | 146,100 |
| 2021/01/08 | 4,070 | 4,110 | 4,045 | 4,095 | +10 | +0.2% | 167,000 |
| 2021/01/07 | 4,145 | 4,160 | 4,075 | 4,085 | -20 | -0.5% | 210,300 |
1051～
1100
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 399,000円 | +3.6% | +6.1% | 3.01% | 13.44倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
